Wahlstrom Mats

Wahlstrom Mats is listed in filings as Director at TriSalus Life Sciences, Inc.. This profile follows SEC Form 4 activity through May 18, 2026, including purchase activity and sale activity. Recent filings connect the profile to TriSalus Life Sciences, Inc. (TLSI) and Coherus Oncology, Inc. (CHRS). The current snapshot covers public activity from Aug 21, 2024 to May 18, 2026. Reported amounts are shown as $151.8K to $88.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.